D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice

Journal of Neuroscience

Volumn 33, Issue 46, 2013, Pages 18125-18133

  Medvedev, Ivan O ^a   Ramsey, Amy J ^b   Masoud, Shababa T ^b   Bermejo, Marie Kristel ^b   Urs, Nikhil ^a   Sotnikova, Tatyana D ^c   Beaulieu, Jean Martin ^f   Gainetdinov, Raul R ^c,d,e   Salahpour, Ali ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^e ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^f CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; APOMORPHINE; BENZAZEPINE DERIVATIVE; CARBIDOPA; COCAINE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; INOSITOL TRISPHOSPHATE; LEVODOPA; METIROSINE; PHOSPHOLIPASE C BETA; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CLIMBING; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; HYPERACTIVITY; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; FEMALE; MALE; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; PROTEIN BINDING;

ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PHOSPHOLIPASE C BETA; PROTEIN BINDING; RECEPTORS, DOPAMINE D1;

EID: 84887361148     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2382-13.2013     Document Type: Article

References (45)

1. Bateup HS, Santini E, Shen W, Birnbaum S, Valjent E, Surmeier DJ, Fisone G, Nestler EJ, Greengard P (2010) Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci U S A 107:14845-14850. CrossRef Medline
2. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182-217. CrossRef Medline
3. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261-273. CrossRef Medline
4. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC Jr, Nairn AC, Greengard P (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402:669-671. CrossRef Medline
5. Brandon EP, Logue SF, Adams MR, Qi M, Sullivan SP, Matsumoto AM, Dorsa DM, Wehner JM, McKnight GS, Idzerda RL (1998) Defective motor behavior and neural gene expression in RIIβ-protein kinase A mutant mice. J Neurosci 18:3639-3649. Medline
6. Carlsson A (2001) A paradigm shift in brain research. Science 294:1021-1024. CrossRef Medline
7. Chartoff EH, Heusner CL, Palmiter RD (2005) Dopamine is not required for the hyperlocomotor response toNMDAreceptor antagonists. Neuropsychopharmacology 30:1324-1333. CrossRef Medline
8. Chow HL, Beck HM (1984) The effect of apomorphine on the open-field behavior of rats: alone and in pairs. Pharmacol Biochem Behav 21:85-88. CrossRef Medline
9. Chun LS, Free RB, Doyle TB, Huang XP, Rankin ML, Sibley DR (2013) D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms. Mol Pharmacol 84:190-200. CrossRef Medline
10. Corvol JC, Valjent E, Pascoli V, Robin A, Stipanovich A, Luedtke RR, Belluscio L, Girault JA, Hervé D (2007) Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Neuropsychopharmacology 32:1109-1121. CrossRef Medline
11. Costa RM, Lin SC, Sotnikova TD, Cyr M, Gainetdinov RR, Caron MG, Nicolelis MA (2006) Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron 52:359-369. CrossRef Medline
12. Dzirasa K, Ribeiro S, Costa R, Santos LM, Lin SC, Grosmark A, Sotnikova TD, Gainetdinov RR, Caron MG, Nicolelis MA (2006) Dopaminergic control of sleep-wake states. J Neurosci 26:10577-10589. CrossRef Medline
13. Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, et al. (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281:838-842. CrossRef Medline
14. Friedman E, Jin LQ, Cai GP, Hollon TR, Drago J, Sibley DR, Wang HY (1997) D1-like dopaminergic activation of phosphoinositide hydrolysis is independent ofD1Adopamine receptors: evidence fromD1Aknockout mice. Mol Pharmacol 51:6-11. Medline
15. Gainetdinov RR, Mohn AR, Bohn LM, Caron MG (2001) Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci U S A 98:11047-11054. CrossRef Medline
16. Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A (2009) Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cell Signal 21:87-94. CrossRef Medline
17. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612. CrossRef Medline
18. Greengard P (2001) The neurobiology of slow synaptic transmission. Science 294:1024-1030. CrossRef Medline
19. Hasbi A, Fan T, Alijaniaram M, Nguyen T, Perreault ML, O'Dowd BF, George SR (2009) Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci U S A 106:21377-21382. CrossRef Medline
20. Hasbi A, O'Dowd BF, George SR (2010) Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms. Curr Opin Pharmacol 10:93-99. CrossRef Medline
21. Hnasko TS, Perez FA, Scouras AD, Stoll EA, Gale SD, Luquet S, Phillips PE, Kremer EJ, Palmiter RD (2006) Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proc Natl Acad Sci U S A 103:8858-8863. CrossRef Medline
22. Johnston TH, Lee J, Gomez-Ramirez J, Fox SH, Brotchie JM (2005) A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease. Exp Neurol 191:243-250. CrossRef Medline
23. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad SciU S A 95:4029-4034. CrossRef Medline
24. Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HH, MacDonald JF (2002) A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35: 1111-1122. CrossRef Medline
25. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lança AJ, O'Dowd BF, George SR (2004) Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279: 35671-35678. CrossRef Medline
26. Managò F, Espinoza S, Salahpour A, Sotnikova TD, Caron MG, Premont RT, Gainetdinov RR (2012) The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment. Sci Rep 2:301. CrossRef Medline
27. Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR, Caron MG (2008) Antagonism of dopamine D2 receptor/betaarrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci U S A 105:13656-13661. CrossRef Medline
28. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225. Medline
29. Nally RE, McNamara FN, Clifford JJ, Kinsella A, Tighe O, Croke DT, Fienberg AA, Greengard P, Waddington JL (2003) Topographical assessment of ethological and dopamine receptor agonist-induced behavioral phenotype in mutants with congenic DARPP-32 "knockout. " Neuropsychopharmacology 28:2055-2063. CrossRef Medline
30. Neve KA (2010) The dopamine receptors. New York: Humana.
31. Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24:165-205. CrossRef Medline
32. Perreault ML, Hasbi A, Alijaniaram M, Fan T, Varghese G, Fletcher PJ, Seeman P, O'Dowd BF, George SR (2010) The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem 285:36625-36634. CrossRef Medline
33. Perreault ML, Hasbi A, O'Dowd BF, George SR (2011) The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in basal ganglia. Front Neuroanat 5:31. CrossRef Medline
34. Rajagopal S, Rajagopal K, Lefkowitz RJ (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 9:373-386. CrossRef Medline
35. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A 104:654-659. CrossRef Medline
36. Roche KW, O'Brien RJ, Mammen AL, Bernhardt J, Huganir RL (1996) Characterization of multiple phosphorylation sites on theAMPAreceptor GluR1 subunit. Neuron 16:1179-1188. CrossRef Medline
37. Sahin B, Hawasli AH, Greene RW, Molkentin JD, Bibb JA (2008) Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C. Eur J Pharmacol 581:270-275. CrossRef Medline
38. Sahu A, Tyeryar KR, Vongtau HO, Sibley DR, Undieh AS (2009) D5 dopamine receptors are required for dopaminergic activation of phospholipase C. Mol Pharmacol 75:447-453. CrossRef Medline
39. Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR (2005) Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol 3:e271. CrossRef Medline
40. Undie AS, Friedman E (1990) Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253:987-992. Medline
41. Undie AS, Berki AC, BeardsleyK (2000) Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways. Neuropharmacology 39:75-87. CrossRef Medline
42. Undieh AS (2010) Pharmacology of signaling induced by dopamine D(1)-like receptor activation. Pharmacol Ther 128:37-60. CrossRef Medline
43. Verma V, Hasbi A, O'Dowd BF, George SR (2010) Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2. J Biol Chem 285:35092-35103. CrossRef Medline
44. Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ (2006) Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology 31:555-562. CrossRef Medline
45. OLFα mediates dopamineD1 receptor signaling. J Neurosci 20:RC91. Medline